Novel dual multiplex real-time RT-PCR assays for the rapid detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus using the BD MAX open system

References

• Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239–1242.
   PubMed Web of Science ®Google Scholar
• Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–733.
   PubMed Web of Science ®Google Scholar
• Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. 2020;92(4):401–402.
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Coronavirus disease (COVID-19): weekly epidemiological update (27 October 2020). 2020. Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update—27-october-2020.
   Google Scholar
• The Lancet Editorial. Emerging understandings of 2019-nCoV. Lancet. 2020;395(10221):311.
   Web of Science ®Google Scholar
• Wang C, Horby PW, Hayden FG, et al. A novel coronavirus outbreak of global health concern. Lancet. 2020;395(10223):470–473.
   PubMed Web of Science ®Google Scholar
• Vellingiri B, Jayaramayya K, Iyer M, et al. COVID-19: a promising cure for the global panic. Sci Total Environ. 2020;725:138277.
   PubMed Web of Science ®Google Scholar
• Arshad Ali S, Baloch M, Ahmed N, et al. The outbreak of coronavirus disease 2019 (COVID-19)-An emerging global health threat. J Infect Public Health. 2020;13(4):644–646.
   PubMed Web of Science ®Google Scholar
• WHO. Novel coronavirus (2019-nCoV) situation report – 11. Geneva: World Health Organization; 2020.
   Google Scholar
• Loeffelholz MJ, Tang YW. Laboratory diagnosis of emerging human coronavirus infections - the state of the art. Emerg Microbes Infect. 2020;9(1):747–756.
   PubMed Web of Science ®Google Scholar
• Baek YH, Um J, Antigua KJC, et al. Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2. Emerg Microbes Infect. 2020;9(1):998–1007.
   PubMed Web of Science ®Google Scholar
• Chan JF, Yip CC, To KK, et al. Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-polymerase chain reaction assay validated in vitro and with clinical specimens. J Clin Microbiol. 2020;58(5):e00310-20.
   PubMed Web of Science ®Google Scholar
• Ai JW, Zhang Y, Zhang HC, et al. Era of molecular diagnosis for pathogen identification of unexplained pneumonia, lessons to be learned. Emerg Microbes Infect. 2020;9(1):597–600.
   PubMed Web of Science ®Google Scholar
• Perng C-L, Jian M, Chang C-K, et al. Novel rapid identification of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by real-time RT-PCR using BD max open system in Taiwan. PeerJ. 2020;8:e9318.
   Web of Science ®Google Scholar
• Wu X, Cai Y, Huang X, et al. Co-infection with SARS-CoV-2 and influenza A virus in patient with pneumonia, China. Emerg Infect Dis. 2020;26(6):1324–1326.
   PubMed Web of Science ®Google Scholar
• Nowak MD, Sordillo EM, Gitman MR, et al. Co-infection in SARS-CoV-2 infected patients: where are influenza virus and rhinovirus/enterovirus? J Med Virol. 2020. published online Apr 30; doi: https://doi.org/10.1002/jmv.25953.
   Google Scholar
• Lai CC, Wang CY, Hsueh PR. Co-infections among patients with COVID-19: the need for combination therapy with non-anti-SARS-CoV-2 agents? J Microbiol Immunol Infect. 2020;53(4):505–512.
   PubMedGoogle Scholar
• Yu X, Wei D, Chen Y, et al. Retrospective detection of SARS-CoV-2 in hospitalized patients with influenza-like illness. Emerg Microbes Infect. 2020;9(1):1470–1473.
   PubMed Web of Science ®Google Scholar
• Hirotsu Y, Maejima M, Shibusawa M, et al. Analysis of Covid-19 and non-Covid-19 viruses, including influenza viruses, to determine the influence of intensive preventive measures in Japan. J Clin Virol. 2020;129:104543.
   Web of Science ®Google Scholar
• Lansbury L, Lim B, Baskaran V, et al. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81(2):266–275.
   PubMed Web of Science ®Google Scholar
• Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance. 2020;25(3):2000045.
   Web of Science ®Google Scholar
• Chen CJ, Hsieh LL, Lin SK, et al. Optimization of the CDC protocol of molecular diagnosis of COVID-19 for timely diagnosis. Diagnostics (Basel). 2020;10(5):333.
   Google Scholar
• Lu X, Wang L, Sakthivel SK, et al. US CDC real-time reverse transcription PCR panel for detection of severe acute respiratory syndrome coronavirus 2. Emerg Infect Dis. 2020 Aug;26(8):1654–1665.
   PubMed Web of Science ®Google Scholar
• Nakauchi M, Yasui Y, Miyoshi T, et al. One-step real-time reverse transcription-PCR assays for detecting and subtyping pandemic influenza A/H1N1 2009, seasonal influenza A/H1N1, and seasonal influenza A/H3N2 viruses. J Virol Methods. 2011;171(1):156–162.
   Web of Science ®Google Scholar
• van der Vries E, Anber J, van der Linden A, et al. Molecular assays for quantitative and qualitative detection of influenza virus and oseltamivir resistance mutations. J Mol Diagn. 2013;15(3):347–354.
   Web of Science ®Google Scholar
• Stokes W, Simner PJ, Mortensen J, et al. Multicenter clinical validation of the molecular BD max enteric viral panel for detection of enteric pathogens. J Clin Microbiol. 2019;57(9):e00306-19.
   Web of Science ®Google Scholar
• Mostafa HH, Hardick J, Morehead E, et al. Comparison of the analytical sensitivity of seven commonly used commercial SARS-CoV-2 automated molecular assays. J Clin Virol. 2020;130:104578.
   PubMed Web of Science ®Google Scholar
• Creager HM, Cabrera B, Schnaubelt A, et al. Clinical evaluation of the biofire(R) respiratory panel 2.1 and detection of SARS-CoV-2. J Clin Virol. 2020;129:104538.
   PubMed Web of Science ®Google Scholar
• Visseaux B, Le Hingrat Q, Collin G, et al. Evaluation of the QIAstat-Dx respiratory SARS-CoV-2 panel, the first rapid multiplex PCR commercial assay for SARS-CoV-2 detection. J Clin Microbiol. 2020 Jul 23;58(8):e00630-20.
   Web of Science ®Google Scholar
• Brendish NJ, Poole S, Naidu VV, et al. Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study. Lancet Respir Med. 2020;8(12):1192–1200.
   PubMed Web of Science ®Google Scholar